HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2007.099366v1 54/2/249    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Ridker, P. M Search for Related Content PubMed PubMed Citation Articles by Ridker, P. M

Rationale, Design, and Methodology of the Women’s Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women

¹ Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Boston; ² Donald W Reynolds Center for Cardiovascular Research, Harvard Medical School, Boston; ³ Amgen, Inc, Cambridge, MA.

^aAddress correspondence to this author at: Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, 900 Commonwealth Ave East, Boston, MA 02215. Fax 617 734-1508; e-mail pridker{at}partners.org.

The primary aim of the Women’s Genome Health Study (WGHS) is to create a comprehensive, fully searchable genome-wide database of >360 000 single nucleotide polymorphisms among at least 25 000 initially healthy American women participating in the ongoing NIH-funded Women’s Health Study (WHS). These women have already been followed over a 12-year period for major incident health events including but not limited to myocardial infarction, stroke, cancer, diabetes, osteoporosis, venous-thromboembolism, cognitive decline, and common visual disorders such as age- related macular degeneration and cataracts. Investigations within the WGHS will seek to identify relevant patterns of genetic polymorphism that predict future disease states in otherwise healthy American women, and to evaluate patterns of genetic polymorphism that relate to multiple intermediate phenotypes including blood-based determinants of disease that were measured at baseline for each study participant. By linking genome-wide data to the existing epidemiologic databank of the parent WHS, which includes comprehensive dietary, behavioral, and traditional exposure data on each participant since cohort inception in 1992, the WGHS will also allow exploration of gene-environment and gene-gene interactions as they relate to incident disease states. Thus, with continued follow-up of the WHS, the WGHS provides a unique scientific resource—a full-cohort, prospective, genome-wide association study among initially healthy American women.

The following articles in journals at HighWire Press have cited this article:

				P. Libby, P. M. Ridker, G. K. Hansson, and for the Leducq Transatlantic Network on Atherothro Inflammation in Atherosclerosis From Pathophysiology to Practice. J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2129 - 2138. [Abstract] [Full Text] [PDF]

				A. Dehghan, Q. Yang, A. Peters, S. Basu, J. C. Bis, A. R. Rudnicka, M. Kavousi, M.-H. Chen, J. Baumert, G. D.O. Lowe, et al. Association of Novel Genetic Loci With Circulating Fibrinogen Levels: A Genome-Wide Association Study in 6 Population-Based Cohorts Circ Cardiovasc Genet, April 1, 2009; 2(2): 125 - 133. [Abstract] [Full Text] [PDF]

				G. Pare, D. I. Chasman, A. N. Parker, R. R.Y. Zee, A. Malarstig, U. Seedorf, R. Collins, H. Watkins, A. Hamsten, J. P. Miletich, et al. Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women's Genome Health Study Circ Cardiovasc Genet, April 1, 2009; 2(2): 142 - 150. [Abstract] [Full Text] [PDF]

				J. S. Danik, G. Pare, D. I. Chasman, R. Y.L. Zee, D. J. Kwiatkowski, A. Parker, J. P. Miletich, and P. M Ridker Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women: The Women's Genome Health Study Circ Cardiovasc Genet, April 1, 2009; 2(2): 134 - 141. [Abstract] [Full Text] [PDF]

				R. Y.L. Zee, R. J. Glynn, S. Cheng, L. Steiner, L. Rose, and P. M Ridker An Evaluation of Candidate Genes of Inflammation and Thrombosis in Relation to the Risk of Venous Thromboembolism: The Women's Genome Health Study Circ Cardiovasc Genet, February 1, 2009; 2(1): 57 - 62. [Abstract] [Full Text] [PDF]

				P. M. Ridker, G. Pare, A. N. Parker, R. Y.L. Zee, J. P. Miletich, and D. I. Chasman Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction: Genomewide Analysis Among 18 245 Initially Healthy Women From the Women's Genome Health Study Circ Cardiovasc Genet, February 1, 2009; 2(1): 26 - 33. [Abstract] [Full Text] [PDF]

				N. P. Paynter, D. I. Chasman, J. E. Buring, D. Shiffman, N. R. Cook, and P. M. Ridker Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3 Ann Intern Med, January 20, 2009; 150(2): 65 - 72. [Abstract] [Full Text] [PDF]

				D. I. Chasman, G. Pare, and P. M Ridker Population-Based Genomewide Genetic Analysis of Common Clinical Chemistry Analytes Clin. Chem., January 1, 2009; 55(1): 39 - 51. [Abstract] [Full Text] [PDF]

				T. A. Pearson and T. A. Manolio How to Interpret a Genome-wide Association Study JAMA, March 19, 2008; 299(11): 1335 - 1344. [Abstract] [Full Text] [PDF]